Skip to main content
Clinical Trials/NCT00527696
NCT00527696TerminatedPhase 3

Randomized Clinical Trial Comparing TVT SECUR System (TVT S) and Trans Vaginal Obturator Tape (TVT-O) for Surgical Management of Stress Urinary Incontinence

University of Manitoba1 site in 1 country106 target enrollmentStarted: May 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Status
Terminated
Enrollment
106
Locations
1
Primary Endpoint
Objective cure as defined by the cough test at one year from surgery

Study Overview

Brief Summary

To compare the efficacy and complications of the TVT SECUR system (TVT S) and trans-vaginal obturator tape (TVT-O) procedures for the surgical management of female stress urinary incontinence.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Female patients with symptoms of stress urinary incontinence and a positive cough test who require surgical management. Cough test is positive when leakage of urine is seen from the urethra synchronously with the patient performing a cough or valsalva manuver with a comfortably full bladder in the lying or standing position.

Exclusion Criteria

  • •Women with predominantly symptoms of urge urinary incontinence
  • •Presence of prolapse greater than Pelvic organ prolapse quantification (POPQ) Stage 1 or prolapse requiring surgery
  • •Detrusor overactivity on cystometrogram at urodynamic testing
  • •Previous surgery for incontinence
  • •Intrinsic sphincter deficiency (MUCP<20 cm H2O or Q -tip <30o)
  • •Voiding dysfunction with postvoid residual >100 cc

Arms & Interventions

TVT SECURE

Active Comparator

sling

Intervention: transvaginal obturator tape (Procedure)

TVT O

Active Comparator

sling

Intervention: transvaginal obturator tape (Procedure)

Outcomes

Primary Outcomes

Objective cure as defined by the cough test at one year from surgery

Time Frame: one year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ken Maslow

Assistant professor

University of Manitoba

Study Sites (1)

Loading locations...

Similar Trials